Clinical Significance and Prognostic Value of Prenatal Diagnosis of Obliteration of the Cavum Septum Pellucidum

Recruiting now

Conditions studied: Fetal Neurodevelopmental Disorder, Cavum Septum Pellucidum

In brief

The aim of this observational study is to evaluate the incidence of the occurrence of additional abnormalities in fetuses diagnosed with cavum septum pellucidum (CSP) obliteration performed at second-trimester ultrasound, as well as to analyze the postnatal neurological outcome.

Key facts

Study ID

NCT06782802

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

15

Starts

2022-03-07

Expected to finish

2026-12-31

Last updated by the study team

2025-01-20

Who can join

Age: 0 and older, up to 44. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant participants with a diagnosis of cavum septum pellucidum obliteration made at second-trimester morphologic ultrasound between 19+0 and 21+6 weeks
• Age > or = 18 years at the time of outpatient access
• Acquisition of informed consent form, from the patient and minor
• Patients followed at our center

You may not qualify if…

• None

Where it is running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.